PHARM VENTURES
GenericsPHARM VENTURES is a generic drug manufacturer focused on Neurology.
Upcoming FDA Decisions
Full Calendar →PHARM VENTURES's Key Drugs
PHARM VENTURES's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PHARM VENTURES's Recent FDA Approvals
New NDA/BLA approvals for PHARM VENTURES over the last two years — novel drugs only, excluding generics and label supplements.
PHARM VENTURES's Therapeutic Areas
PHARM VENTURES's approved drugs and pipeline span 1 therapeutic area, led by Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PHARM VENTURES's Top Competitors
PHARM VENTURES's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PHARM VENTURES Pipeline Snapshot
Active clinical trials for PHARM VENTURES across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1989-04-07
- Latest
- 1998-02-06
- Applications
- 1